Sodium intake and vascular stiffness in hypertension

Hypertension

Volumn 54, Issue 2, 2009, Pages 203-209

  Safar, Michel E ^a,e   Temmar, Mohamed ^b   Kakou, Augustine ^c,d   Lacolley, Patrick ^c,d   Thornton, Simon N ^c,d  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b Cardiology Center   (Algeria)

^c INSERM   (France)

^d UNIVERSITÉ DE LORRAINE   (France)

^e HÔTEL DIEU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE SYNTHASE; ALPHA ADDUCIN; ANGIOTENSIN II; DEXTRAN; EPLERENONE; FIBRONECTIN; GLYCOSAMINOGLYCAN; POTASSIUM; SODIUM;

ARTERIAL STIFFNESS; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; ENDOTHELIUM CELL; GENETIC POLYMORPHISM; HEART STROKE VOLUME; HEART VENTRICLE EJECTION; HEMODYNAMIC MONITORING; HUMAN; HYPERTENSION; KIDNEY BLOOD FLOW; MOLECULAR MECHANICS; PRIORITY JOURNAL; REVIEW; SODIUM INTAKE; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASE; DRUG EFFECT; FEMALE; HEART FUNCTION TEST; MALE; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIUM; VASCULAR PATENCY; VASCULAR RESISTANCE;

BLOOD FLOW VELOCITY; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; FEMALE; HEART FUNCTION TESTS; HUMANS; HYPERTENSION; MALE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SODIUM; SODIUM, DIETARY; VASCULAR PATENCY; VASCULAR RESISTANCE;

EID: 68549122788     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.129585     Document Type: Review

References (46)

1. Safar ME, O'Rourke ME. Arterial Stiffness in Hypertension. Handbook of Hypertension. Edinburgh: Elsevier; 2006;136:3-62, 75-88, 459-501.
2. De Wardener HE, MacGregor GA. Sodium and blood pressure. Curr Opin Cardiol. 2002;17:360-367.
3. Frohlich ED. The salt conundrum: a hypothesis. Hypertension. 2007;50: 161-166.
4. Guyton AC. Arterial Pressure and Hypertension. Circulatory Physiology III. Philadelphia, PA: Saunders; 1980;334:71-116, 293-304, 370-374.
5. Alderman MH. Presidential Address: 21st Scientific Meeting of the International Society of Hypertension: dietary sodium and cardiovascular disease: the 'J'-shaped relation. J Hypertens. 2007;25:903-907.
6. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA. Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev. 2005;85:679-715.
7. Weinberger MH. Sodium and blood pressure 2003. Curr Opin Cardiol. 2004;19:353-356.
8. Denton D, Weisinger R, Mundy NI, Wickings EJ, Dixson A, Moisson P, Pingard AM, Shade R, Carey D, Ardaillou R, Paillard F, Chapman G, Thillet J, Michel JB. The effect of increased salt intake on blood pressure of chimpanzees. Nat Med. 1995;1:1009-1016.
9. Mitchell GF, Parise H, Benjamin EJ, Larson MG, Keyes MJ, Vita JA, Vasan RS, Levy D. Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study. Hypertension. 2004;43:1239-1245.
10. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure-results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
11. Simon G, Illyes G, Csiky B. Structural vascular changes in hypertension: role of angiotensin II, dietary sodium supplementation, blood pressure, and time. Hypertension. 1998;32:654-660.
12. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, Pietinen P, Nissinen A. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;357:848-851.
13. Adrogue HJ, Madias NE. Sodium and potassium in the pathogenesis of hypertension. N Engl J Med. 2007;356:1966-1978.
14. Mercier N, Labat C, Louis H, Cattan V, Benetos A, Safar ME, Lacolley P. Sodium, arterial stiffness, and cardiovascular mortality in hypertensive rats. Am J Hypertens. 2007;20:319-325.
15. Fitzsimons JT. Angiotensin, thirst, and sodium appetite. Physiol Rev. 1998;78:583-686.
16. Bianchi G, Baer PG, Fox U, Duzzi L, Pagetti D, Giovannetti AM. Changes in renin, water balance, and sodium balance during development of high blood pressure in genetically hypertensive rats. Circ Res. 1975;36:153-161.
17. Safar ME, Plante GE, London GM. Vascular compliance and blood volume in essentiel hypertension. In: Laragh JH, Brenner BM, eds. Hypertension, Pathophysiology, Diagnosis, Management. New York, NY: Raven Press; 1995:377-388.
18. Tarazi RC. Hemodynamic role of extracellular fluid in hypertension. Circ Res. 1976;38:73-83.
19. Safar ME, London GM, Levenson JA, Simon AC, Chau NP. Rapid dextran infusion in essential hypertension. Hypertension. 1979;1: 615-623.
20. Chau NP, Coleman TG, London GM, Safar ME. Meaning of the cardiac output-blood volume relationship in essential hypertension. Am J Physiol. 1982;243:R318-R328.
21. Thakali KM, Galligan JJ, Fink GD, Watts SW. Arterial and venous function in hypertension. In: Lip GYH, Hall JE, eds. Comprehensive Hypertension. Edinburgh, United Kingdom: Elsevier; 2007:205-222.
22. Grassi G, Giannattasio C, Saino A, Sabadini E, Capozi A, Sampieri L, Cuspidi C, Mancia G. Cardiopulmonary receptor modulation of plasma renin activity in normotensive and hypertensive subjects. Hypertension. 1988;11:92-99.
23. Mark A, Mancia G. Cardiopulmonary baroreflexes in humans. In: Shepherd JT, Abboud FM, eds. Handbook of Physiology. Section 2, The Cardiovascular System. Bethesda, Md: American Physiological Society. 1983:795-813.
24. Safar ME, Thuilliez C, Richard V, Benetos A. Pressure-independent contribution of sodium to large artery structure and function in hypertension. Cardiovasc Res. 2000;46:269-276.
25. Benetos A, Levy BI, Lacolley P, Taillard F, Duriez M, Safar ME. Role of angiotensin II and bradykinin on aortic collagen following converting enzyme inhibition in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1997;17:3196-3201.
26. Partovian C, Benetos A, Pommies JP, Mischler W, Safar ME. Effects of a chronic high-salt diet on large artery structure: role of endogenous bradykinin. Am J Physiol. 1998;274:H14230-H14238.
27. Avolio AP, Deng FQ, Li WQ, Luo YF, Huang ZD, Xing LF, O'Rourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Circulation. 1985;71:202-210.
28. Avolio AP, Clyde KM, Beard TC, Cooke HM, Ho KK, O'Rourke MF. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166-169.
29. Benetos A, Xiao YY, Cuche JL, Hannaert P, Safar M. Arterial effects of salt restriction in hypertensive patients: a 9-week, randomized, doubleblind, crossover study. J Hypertens. 1992;10:355-360.
30. Gates PE, Tanaka H, Hiatt WR, Seals DR. Dietary sodium restriction rapidly improves large elastic artery compliance in older adults with systolic hypertension. Hypertension. 2004;44:35-41.
31. Sudhir K, Kurtz TW, Yock PG, Connolly AJ, Morris RC Jr. Potassium preserves endothelial function and enhances aortic compliance in Dahl rats. Hypertension. 1993;22:315-322.
32. Blaustein MP. Sodium ions, calcium ions, blood pressure regulation, and hypertension: a reassessment and a hypothesis. Am J Physiol. 1977;232: C165-C173.
33. Dobrin PB. Mechanical factors associated with the development of intimal and medial thickening in vein grafts subjected to arterial pressure: a model of arteries exposed to hypertension. Hypertension. 1995;26: 38-43.
34. Oberleithner H, Riethmuller C, Schillers H, MacGregor GA, de Wardener HE, Hausberg M. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci U S A. 2007;104: 16281-16286.
35. Sanders PW. Salt intake, endothelial cell signaling, and progression of kidney disease. Hypertension. 2004;43:142-146.
36. Zineh I, Beitelshees AL, Haller MJ. NOS3 polymorphisms are associated with arterial stiffness in children with type 1 diabetes. Diabetes Care. 2007;30:689-693.
37. Bezie Y, Lamaziere JM, Laurent S, Challande P, Cunha RS, Bonnet J, Lacolley P. Fibronectin expression and aortic wall elastic modulus in spontaneously hypertensive rats. Arterioscler Thromb Vasc Biol. 1998;18:1027-1034.
38. Labat C, Lacolley P, Lajemi M, de Gasparo M, Safar ME, Benetos A. Effects of valsartan on mechanical properties of the carotid artery in spontaneously hypertensive rats under high-salt diet. Hypertension. 2001;38:439-443.
39. Louis H, Kakou A, Regnault V, Labat C, Bressenot A, Gao-Li J, Gardner H, Thornton SN, Challande P, Li Z, Lacolley P. Role of alpha1beta1-integrin in arterial stiffness and angiotensin-induced arterial wall hypertrophy in mice. Am J Physiol Heart Circ Physiol. 2007;293: H2597-H2604.
40. Lacolley P, Labat C, Pujol A, Delcayre C, Benetos A, Safar M. Increased carotid wall elastic modulus and fibronectin in aldosterone-salt-treated rats: effects of eplerenone. Circulation. 2002;106:2848-2853.
41. Varagic J. A paradigme for a local cardiac renin-angiotensin-aldosterone system. In: Frohlich ED, Re RN, eds. The Local Cardiac Renin-Angio-tensin- Aldosterone System. New York, NY: Springer Science, Business Media; 2005:61-72.
42. Nickenig G, Strehlow K, Roeling J, Zolk O, Knorr A, Bohm M. Salt induces vascular AT1 receptor overexpression in vitro and in vivo. Hypertension. 1998;31:1272-1277.
43. Balkestein EJ, Staessen JA, Wang JG, van Der Heijden-Spek JJ, Van Bortel LM, Barlassina C, Bianchi G, Brand E, Herrmann SM, Struijker-Boudier HA. Carotid and femoral artery stiffness in relation to three candidate genes in a white population. Hypertension. 2001;38: 1190-1197.
44. Safar ME, Cattan V, Lacolley P, Nzietchueng R, Labat C, Lajemi M, de Luca N, Benetos A. Aldosterone synthase gene polymorphism, stroke volume and age-related changes in aortic pulse wave velocity in subjects with hypertension. J Hypertens. 2005;23:1159-1166.
45. Temmar M, Labat C, Benkhedda S, Charifi M, Thomas F, Bouafia MT, Bean K, Darne B, Safar ME, Benetos A. Prevalence and determinants of hypertension in the Algerian Sahara. J Hypertens. 2007;25:2218-2226.
46. Fesler P, Safar ME, du Cailar G, Ribstein J, Mimran A. Pulse pressure is an independent determinant of renal function decline during treatment of essential hypertension. J Hypertens. 2007;25:1915-1920.